drugset / Trial / NCT00164008
Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to see whether zoledronic acid is better than pamidronate to treat low bone density in heart and lung transplant patients.
Timeline
- Start
- 2002-10
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pamidronate | Small molecule | — | — |
| Subject | Zoledronic acid | Other / unclassified | — | — |